Ginkgo Bioworks Announces Participation in William Blair's 42nd Annual Growth Stock Conference
Ginkgo Bioworks (NYSE: DNA) will participate in William Blair's 42nd Annual Growth Stock Conference on June 9, 2022, at 11:20 a.m. CT.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Ginkgo Bioworks (NYSE: DNA) will participate in William Blair's 42nd Annual Growth Stock Conference on June 9, 2022, at 11:20 a.m. CT. The conference aims to showcase growth stocks to investors and provide insights into Ginkgo's cell programming platform, which serves various markets from agriculture to pharmaceuticals. Details about the event, including a webcast link and a replay, can be found on the company's investor relations website.
Positive
- Participation in a prominent investment conference may enhance visibility and investor interest.
- Opportunity to discuss innovative biotechnology applications across multiple industries.
Negative
- None.
Details
News Market Reaction – DNA
The recorded move for DNA in the trading session of this news was +5.17%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
BOSTON, June 2, 2022 /PRNewswire/ -- Ginkgo Bioworks (NYSE: DNA), the leading horizontal platform for cell programming, announced today that management is scheduled to participate in William Blair's 42nd Annual Growth Stock Conference, on June 9, 2022, at 11:20 a.m. CT.
Further details, a webcast link, and a replay of the presentation, if available, will be posted on the company's investor relations website at https://investors.ginkgobioworks.com/events.
About Ginkgo Bioworks
Ginkgo is building a platform to enable customers to program cells as easily as we can program computers. The company's platform is enabling biotechnology applications across diverse markets, from food and agriculture to industrial chemicals to pharmaceuticals. Ginkgo has also actively supported a number of COVID-19 response efforts, including K-12 pooled testing, vaccine manufacturing optimization, and therapeutics discovery. For more information, visit www.ginkgobioworks.com.
Ginkgo Bioworks Contacts:
INVESTOR CONTACT:
investors@ginkgobioworks.com
MEDIA CONTACT:
press@ginkgobioworks.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/ginkgo-bioworks-announces-participation-in-william-blairs-42nd-annual-growth-stock-conference-301560527.html
SOURCE Ginkgo Bioworks
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.